Schwannomas of the Sellar and Parasellar Region



Fig. 30.1
Schwannoma of the trigeminal nerve. Coronal T1-weighted gadolinium-enhanced MR image. A large enhancing mass is centered in the left parasellar region



A307296_1_En_30_Fig2_HTML.gif


Fig. 30.2
Trigeminal schwannoma. (a) Axial T1-weighted gadolinium-enhanced image. (b) Coronal T1-weighted gadolinium-enhanced image. There is a large right parasellar, enhancing mass centered in the right Meckel’s cave, extending through the right foramen ovale


A307296_1_En_30_Fig3_HTML.gif


Fig. 30.3
Maxillary nerve schwannoma. (a) Sagittal T1-weighted gadolinium-enhanced image. (b) Coronal T1-weighted gadolinium-enhanced image. (c) Axial T1-weighted gadolinium-enhanced image. There is a heterogeneously enhancing mass (arrows) centered immediately below the left foramen ovale, extending anteriorly to the left pterygopalatine fossa


A307296_1_En_30_Fig4_HTML.gif


Fig. 30.4
Schwannoma. (a) Sagittal T1-weighted non-enhanced image. (b) Coronal T2-weighted image. (c) Sagittal CT image in bone algorithm. (d) Coronal CT image in soft tissue algorithm. A heterogeneously enhancing mass is centered in the right posterior ethmoid, with marked bony remodeling superiorly, medially, and inferiorly. Superiorly, the mass expands into the right anterior cranial fossa abutting the frontal lobe. Medially, the mass displaces the bony septum and narrows the sphenoid sinuses. Inferiorly, the mass expands into the nasal cavity. The sphenoid sinuses are completely obstructed




30.3 Histopathology






  • Typical histopathological features of parasellar and sinonasal schwannoma include spindle cell proliferation with low mitotic activity and a low MIB-1 labeling index.


  • Diffuse immunoreactivity for S100 is typically noted, with negative staining of CD34 and epithelial membrane antigen (EMA) [6].


  • Classic features of schwannoma—cellular Antoni A and loose Antoni B areas, Verocay bodies, and hyalinized, thickened vessels—are typically observed but not always found in parasellar and sinonasal schwannoma (Fig. 30.5) [7, 8].


  • Rare, malignant schwannomas with rhabdomyoblastic differentiation (Triton tumors) of the parasellar or sinonasal region have been reported; these tumors require multimodality treatment with radiation and chemotherapy [9].


A307296_1_En_30_Fig5_HTML.gif


Fig. 30.5
Schwannoma. (a) A schwannoma consisting of dense fascicles in an Antoni A arrangement and nuclear palisading (H&E, ʿÅ ~20), and (b) Differentiated Schwann cells expressing S-100 protein (Adapted with permission from Rallis et al. [8])


30.4 Clinical and Surgical Management






  • Successful transsphenoidal resection of intrasellar and suprasellar schwannoma has been reported numerous times, typically with improvement in visual function [10, 11].


  • Endonasal endoscopic approaches may be useful for resection of schwannomas arising in the sinonasal region and more laterally or anteriorly in the skull base, such as the cribriform region, sinonasal tract, or pterygopalatine fossa [1214].


  • Schwannomas of the skull base are often characterized by a rich blood supply, making the tumors quite vascular.


  • For primary cavernous sinus (i.e., trigeminal) schwannomas, open craniotomy with an extradural temporopolar or similar approach may be utilized with excellent surgical results. Facial hypoesthesia is the major adverse outcome associated with this approach [1517].


  • Following gross resection of benign parasellar and sinonasal schwannomas, the recurrence rate has been reported to be extremely low (<10 %) [6, 14].


30.4.1 Radiotherapy and Radiosurgery


Mar 11, 2017 | Posted by in NEUROSURGERY | Comments Off on Schwannomas of the Sellar and Parasellar Region

Full access? Get Clinical Tree

Get Clinical Tree app for offline access